dexamethasone,lenalidomide,bortezomib
takeda
['determination']
seems like determination has been the most controversial trial presented with lots of debate among #myeloma #bmt, while the rest of #asco22 is 
Deputy Physician-in-Chief of Blood Cancers @SarahCannonDocs | Director @TriStarHealth BMT Program | President @ASTCT 2019 | #BMTsm #CARTcell #CellTherapy